glp 1 agonists drug class GLP-1 for Weight Loss: Safe or Risky? Understanding incretin-based therapies made simple
Description
Burke OM, Sa B, Cespedes DA, Tosti A
These improvements correlate with weight loss magnitude, though some studies suggest potential benefits beyond weight reduction alone
Several studies have shown that tirzepatide reduces insulin resistance, improves glycemic control, and lowers inflammatory biomarkers, including C-reactive protein and IL-6 (46, 47)
GLP-1 receptor agonists slow down gastric emptying early in treatment, but their effectiveness starts to decrease within 1-2 weeks [24]
